Table 1:
Study Unit |
Activation Date |
Enrolled Subjects () |
Sponsor ID a | Study Number a |
Disease Working Group a |
Title a | Principal Investigator a |
||
---|---|---|---|---|---|---|---|---|---|
12 | 24 | months | 01/10/2017 | 5 | ABCD 1234 | STUDY 001 | Lung | Title: AAAAA | AAA |
25 | 36 | months | 11/25/2015 | 19 | KUCC 1234 | STUDY 002 | Leukemia/Myeloid | Title: BBBBB | BBB |
30 | 36 | months | 07/17/2015 | 28 | KUCC 1001 | STUDY 003 | Breast | Title: CCCCC | CCC |
5 | 12 | months | 12/05/2017 | 3 | ABCD 1001 | STUDY 004 | Lymphoma/Myeloma | Title: DDDDD | DDD |
5 | 18 | months | 04/03/2018 | 4 | ABCD 1002 | STUDY 005 | Lymphoma/Myeloma | Title: EEEEE | EEE |
These values are blinded throughout this paper.